Anaplastic Large Cell Lymphoma, ALK-Positive
Oncology·MeSH: Paget Disease, Extramammary
Prevalence
56.0 / 100K
Incidence
19.6 / 100K/yr
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Anaplastic Large Cell Lymphoma, ALK-Positive?
There are 2 clinical trials targeting Anaplastic Large Cell Lymphoma, ALK-Positive tracked by BioSniper.
What is the prevalence of Anaplastic Large Cell Lymphoma, ALK-Positive?
The estimated prevalence of Anaplastic Large Cell Lymphoma, ALK-Positive is approximately 56.0 per 100,000 population.
Deep-dive into Anaplastic Large Cell Lymphoma, ALK-Positive
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis